{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Wilson",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72324",
      "recalling_firm": "Merck Sharp & Dohme, Wilson Facility",
      "address_1": "4633 Merck Rd W",
      "address_2": "N/A",
      "postal_code": "27893-9613",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "KY, MS and OH.",
      "recall_number": "D-0007-2016",
      "product_description": "Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.",
      "product_quantity": "N/A",
      "reason_for_recall": "Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.",
      "recall_initiation_date": "20150814",
      "center_classification_date": "20151005",
      "termination_date": "20160504",
      "report_date": "20151014",
      "code_info": "Lot number: L013425, Exp. 11/2016"
    }
  ]
}